SE9102014L - Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar - Google Patents

Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar

Info

Publication number
SE9102014L
SE9102014L SE9102014A SE9102014A SE9102014L SE 9102014 L SE9102014 L SE 9102014L SE 9102014 A SE9102014 A SE 9102014A SE 9102014 A SE9102014 A SE 9102014A SE 9102014 L SE9102014 L SE 9102014L
Authority
SE
Sweden
Prior art keywords
determination
pct
characterization
blood cells
antibodies
Prior art date
Application number
SE9102014A
Other languages
Unknown language ( )
English (en)
Other versions
SE9102014D0 (sv
SE469451B (sv
Inventor
Anders Larsson
Tomas Lindahl
Original Assignee
Anders Larsson
Tomas Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Larsson, Tomas Lindahl filed Critical Anders Larsson
Priority to SE9102014A priority Critical patent/SE469451B/sv
Publication of SE9102014D0 publication Critical patent/SE9102014D0/sv
Priority to PCT/SE1992/000451 priority patent/WO1993000585A1/en
Priority to US08/167,877 priority patent/US5776697A/en
Priority to ES92914085T priority patent/ES2097339T3/es
Priority to AU22330/92A priority patent/AU2233092A/en
Priority to EP92914085A priority patent/EP0593558B1/en
Priority to JP5501439A priority patent/JPH06508922A/ja
Priority to DE69216408T priority patent/DE69216408T2/de
Publication of SE9102014L publication Critical patent/SE9102014L/sv
Publication of SE469451B publication Critical patent/SE469451B/sv

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • Y10T436/117497Automated chemical analysis with a continuously flowing sample or carrier stream

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9102014A 1991-06-28 1991-06-28 Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar SE469451B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9102014A SE469451B (sv) 1991-06-28 1991-06-28 Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar
PCT/SE1992/000451 WO1993000585A1 (en) 1991-06-28 1992-06-22 Characterization or determination of the amount of mammalian cells by means of antibodies
US08/167,877 US5776697A (en) 1991-06-28 1992-06-22 Characterization or determination of the amount of blood cells by means of poultry antibodies
ES92914085T ES2097339T3 (es) 1991-06-28 1992-06-22 Caracterizacion o determinacion de la cantidad de celulas de mamifero por medio de anticuerpos.
AU22330/92A AU2233092A (en) 1991-06-28 1992-06-22 Characterization or determination of the amount of mammalian cells by means of antibodies
EP92914085A EP0593558B1 (en) 1991-06-28 1992-06-22 Characterization or determination of the amount of mammalian cells by means of antibodies
JP5501439A JPH06508922A (ja) 1991-06-28 1992-06-22 哺乳動物細胞に関連する方法
DE69216408T DE69216408T2 (de) 1991-06-28 1992-06-22 Charakterisierung oder bestimmung der menge von säugerzellen mittels antikörpern

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102014A SE469451B (sv) 1991-06-28 1991-06-28 Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar

Publications (3)

Publication Number Publication Date
SE9102014D0 SE9102014D0 (sv) 1991-06-28
SE9102014L true SE9102014L (sv) 1992-12-29
SE469451B SE469451B (sv) 1993-07-05

Family

ID=20383193

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9102014A SE469451B (sv) 1991-06-28 1991-06-28 Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar

Country Status (8)

Country Link
US (1) US5776697A (sv)
EP (1) EP0593558B1 (sv)
JP (1) JPH06508922A (sv)
AU (1) AU2233092A (sv)
DE (1) DE69216408T2 (sv)
ES (1) ES2097339T3 (sv)
SE (1) SE469451B (sv)
WO (1) WO1993000585A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1246621A4 (en) * 1999-12-23 2004-11-24 Nitromed Inc NITROSED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS FOR THEIR USE
US9506153B2 (en) 2014-09-17 2016-11-29 The United States Of America As Represented By The Secretary Of The Army Integrated composite perovskite oxide heterostructure
US10032853B2 (en) 2014-09-17 2018-07-24 The United States Of America As Represented By The Secretary Of The Army Microstructural architecture to enable strain relieved non-linear complex oxide thin films

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
SE454812B (sv) * 1986-10-22 1988-05-30 Anders Larsson Forfarande och komposition for uppfangande av eller detektering av immunkomplex och anvendning av fagelantikroppar herfor
US5049502A (en) * 1987-12-31 1991-09-17 Board Of Regents, The University Of Texas System Chicken-derived immunoglobulin-producing cell lines

Also Published As

Publication number Publication date
US5776697A (en) 1998-07-07
EP0593558B1 (en) 1997-01-02
ES2097339T3 (es) 1997-04-01
AU2233092A (en) 1993-01-25
DE69216408T2 (de) 1997-06-26
EP0593558A1 (en) 1994-04-27
SE9102014D0 (sv) 1991-06-28
DE69216408D1 (de) 1997-02-13
SE469451B (sv) 1993-07-05
JPH06508922A (ja) 1994-10-06
WO1993000585A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DE69232782T2 (de) Zielgerichtetes Einbringen eines Virus-Vektors in Säugetierzellen.
SE9203118D0 (sv) A method of preventing undesired binding in solid phase assays
ES2013226T3 (es) Una composicion que genera luz al activarse y su metodo de preparacion.
IT8819024A0 (it) E suo uso. terreno di coltura esente da siero
GB8916400D0 (en) Modified igg3
NL174499B (nl) Amorf lichtgevoelig materiaal in de vorm van waterstofhoudend siliciumcarbide, alsmede drager voorzien van een of meer lagen van dit materiaal.
DE3884641D1 (de) Aufzeichnungsflüssigkeit und Aufzeichnungsverfahren unter Verwendung derselben.
ES509126A0 (es) "un metodo para estabilizar un portaobjetos de muestra para el ensayo de sangre oculta".
SE8804074D0 (sv) Sensorenhet och dess anvaendning i biosensorsystem
DE3880118D1 (de) Verwendung eines mittels in form von mikrokapseln zur schabenbekaempfung.
ES2018185B3 (es) Soporte de prueba y metodo para la clasificacion de parametros de coagulacion
NO932320L (no) Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne
ATE168482T1 (de) Bedingungsfeststellen in asynchronpipeline
DE69012437D1 (de) Druckverfahren für Probe- und Flachdruck unter Nutzung eines elektrophotographischen Aufzeichnungsmittels.
SE9102014L (sv) Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar
IT7924778A0 (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione.
SE7907118L (sv) Bestemning av human beta?712-mikroglobulin
KR850001282A (ko) 심근 미오신 중사슬에 대한 단일클론항체
ATE114817T1 (de) Immunologisches nachweisverfahren für herbizide.
Schremmer-Danninger et al. Autoradiographic visualization of B 1 bradykinin receptors in porcine vascular tissues in the presence or absence of inflammation
EP0319334A3 (en) Method and means for assaying collagenase
ATA261687A (de) Laktoferrin enthaltendes inkubationsmedium für festphasen-immunometrische verfahren und seine verwendung
NL7801264A (nl) Werkwijze voor het verven en bedrukken van in water zwelbaar cellulosemateriaal en mengsels daarvan met synthetische vezels met behulp van diazokleurstoffen, afgeleid van aminopyrazool.
ATE128236T1 (de) Verwendung von atelokollagen als festträger für die fixierung eines spezifischen fängers.
DuPlessis Shorter American Memory

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9102014-9

Format of ref document f/p: F

NUG Patent has lapsed